Reports
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
 |
Everolimus (Afinitor®) |
|
Negative outcome - CDF funded for renal, NET, breast. For hospital use only. |
|
Everolimus (Votubia®) | As recommended by NHSE Refractory seizures associated with tuberous sclerosis |
|
|
Evicel | Hospital use only |
|
|
Evolocumab |
& Homozygous familial hypercholesterola EMIA in line with NHS England SSC 1649 |
To be used in line with NICE TA |
 |
Evra (patches) | Umbrella service only - patients with compliance problems and metabolic problems |
|
 |
Felodipine tablets | Brand rationalisation, APC preferred brands: Cardioplen XL, Felotens XL |
|
|
Fentanyl lozenges | For palliative care use only |
|
|
Fentanyl sublinual tablets | For palliative care use only |
|
|
Ferric maltol (Feraccru®) | For the treatment of iron deficiency anaemia (IDA) in patients with inflammatory bowel disease (IBD), unable to tolerate other oral iron formulations. Supported by a RICaD |
|
|
Ferrous gluconate tablets | If patient intolerant of sulphate. |
- First page
- Previous page
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- Next page
- Last page
Drug status key
Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.
Grey
Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.
Red
Initiation and maintenance of prescribing by specialists only.
Amber
Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.
Green
Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.
Blue
Under review at University Hospitals Birmingham NHS Foundation Trust.
